Insulin Degludec

CCC (C) C (NC (=O) CN) C (=O) NC (C (C) C) C (=O) NC (CCC (O) =O) C (=O) NC (CCC (N) =O) C (=O) NC1CSSCC2NC (=O) C (NC (=O) C (CO) NC (=O) C (NC (=O) C (CSSCC (NC (=O) C (CC (C) C) NC (=O) C (CC3=C[NH]C=N3) NC (=O) C (CCC (N) =O) NC (=O) C (CC (N) =O) NC (=O) C (NC (=O) C (N) CC4=CC=CC=C4) C (C) C) C (=O) NCC (=O) NC (CO) C (=O) NC (CC5=C[NH]C=N5) C (=O) NC (CC (C) C) C (=O) NC (C (C) C) C (=O) NC (CCC (O) =O) C (=O) NC (C) C (=O) NC (CC (C) C) C (=O) NC (CC6=CC=C (O) C=C6) C (=O) NC (CC (C) C) C (=O) NC (C (C) C) C (=O) NC (CSSCC (NC (=O) C (CC7=CC=C (O) C=C7) NC (=O) C (CC (N) =O) NC (=O) C (CCC (O) =O) NC (=O) C (CC (C) C) NC (=O) C (CCC (N) =O) NC (=O) C (CC8=CC=C (O) C=C8) NC (=O) C (CC (C) C) NC (=O) C (CO) NC2=O) C (=O) NC (CC (N) =O) C (O) =O) C (=O) NCC (=O) NC (CCC (O) =O) C (=O) NC (CCCNC (N) =N) C (=O) NCC (=O) NC (CC9=CC=CC=C9) C (=O) NC (CC%10=CC=CC=C%10) C (=O) NC (CC%11=CC=C (O) C=C%11) C (=O) NC (C (C) O) C (=O) N%12CCCC%12C (=O) NC (CCCCNC (=O) CCC (NC (=O) CCCCCCCCCCCCCCC (O) =O) C (O) =O) C (O) =O) NC1=O) C (C) O) C (C) CC

Insulin degludec is an acylated basal insulin with a unique mechanism of protracted absorption involving the formation of a depot of soluble multihexamer chains after subcutaneous injection, shows a very long duration of action, with a half-life exceeding 25 h in PK/PD studies.